07543ZZ
Destruction Lymphatic, Left Upper Extremity to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | 5 Destruction |
| Body Part | 4 Lymphatic, Left Upper Extremity |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the lymphatic and hemic systems eliminate abnormal tissue in place, using heat, cold, chemicals, or other energy sources rather than physically cutting it out. In practice this most often means sclerotherapy or ablation of lymphatic malformations, cystic hygromas, or enlarged lymph nodes, where injecting or applying an agent causes the abnormal tissue to shrink and scar down.
This approach is favored when surgical removal would be difficult or risky, such as malformations located near major blood vessels or nerves, or in children where minimizing surgical trauma matters. It can also be used to manage lymphoceles that have not responded to simple drainage.
Because the tissue is destroyed rather than removed, there is nothing sent to pathology, which is a key practical difference from excisional approaches.
Anatomy & Axis Detail
Lymphatic, Left Upper Extremity
The left upper extremity's lymphatic vessels and nodes mirror those on the right, draining the arm and hand and playing a role in regional immune surveillance as well as fluid balance, with lymphedema being a notable concern following any nodal disruption on this side. Destruction here means diseased or targeted lymphatic tissue is eliminated in place, commonly via a thermal, laser, or chemical modality, leaving the tissue within the body rather than excising it. The distinction from a lymph node dissection is clinically significant, since destructive techniques aim to preserve surrounding lymphatic architecture and reduce the risk of subsequent limb swelling.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Coders should assign Destruction when the documentation describes obliterating tissue in place, through sclerosing agents, laser, radiofrequency, or similar means, with no specimen extracted from the body. The specific agent or energy source used should be reflected in the approach and, where applicable, the qualifier.
A common error is coding a sclerotherapy injection as Introduction of a substance rather than Destruction of the target tissue, since both involve injecting an agent but only one is aimed at eradicating the lymphatic structure itself. Reviewing physician intent and the described tissue effect, rather than just the act of injection, resolves this distinction.